Literature DB >> 29875102

Extracellular galectins as controllers of cytokines in hematological cancer.

Monica Gordon-Alonso1,2, Annika M Bruger1, Pierre van der Bruggen1,2.   

Abstract

Galectins and cytokines are both secreted proteins whose levels are prognosis factors for several cancers. Extracellular galectins bind to the glycans decorating glycoproteins and are overproduced in most cancers. Accumulative evidence shows that galectins regulate cytokines during cancer progression. Although galectins alter cytokine function by binding to the glycans decorating cytokines or their receptors, cytokines could also regulate galectin expression and function. This review revises these complex interactions and their clinical impact, particularly in hematological cancers.
© 2018 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29875102      PMCID: PMC6073326          DOI: 10.1182/blood-2018-04-846014

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  68 in total

1.  CEACAM1 regulates TIM-3-mediated tolerance and exhaustion.

Authors:  Yu-Hwa Huang; Chen Zhu; Yasuyuki Kondo; Ana C Anderson; Amit Gandhi; Andrew Russell; Stephanie K Dougan; Britt-Sabina Petersen; Espen Melum; Thomas Pertel; Kiera L Clayton; Monika Raab; Qiang Chen; Nicole Beauchemin; Paul J Yazaki; Michal Pyzik; Mario A Ostrowski; Jonathan N Glickman; Christopher E Rudd; Hidde L Ploegh; Andre Franke; Gregory A Petsko; Vijay K Kuchroo; Richard S Blumberg
Journal:  Nature       Date:  2014-10-26       Impact factor: 49.962

2.  Complete cDNA sequence of B*4406, an HLA-B allele containing sequences of B*5101 and B*4402.

Authors:  W Zhao; M A Fernandez-Viña; A M Lazaro; H A Araujo; S Miller; P Stastny
Journal:  Tissue Antigens       Date:  1996-05

Review 3.  Galectins as therapeutic targets for hematological malignancies: a hopeful sweetness.

Authors:  Camilo Pena; Leonardo Mirandola; Jose A Figueroa; Nattamol Hosiriluck; Natallia Suvorava; Kayley Trotter; Adair Reidy; Rahman Rakhshanda; Drew Payne; Marjorie Jenkins; Fabio Grizzi; Lauren Littlefield; Maurizio Chiriva-Internati; Everardo Cobos
Journal:  Ann Transl Med       Date:  2014-09

4.  Galectin-1 inhibits the viability, proliferation, and Th1 cytokine production of nonmalignant T cells in patients with leukemic cutaneous T-cell lymphoma.

Authors:  Filiberto Cedeno-Laurent; Rei Watanabe; Jessica E Teague; Thomas S Kupper; Rachael A Clark; Charles J Dimitroff
Journal:  Blood       Date:  2012-03-01       Impact factor: 22.113

Review 5.  Cells regulate the activities of cytokines by glycosylation.

Authors:  G Opdenakker; P M Rudd; M Wormald; R A Dwek; J Van Damme
Journal:  FASEB J       Date:  1995-03       Impact factor: 5.191

Review 6.  Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation.

Authors:  Gabriel A Rabinovich; Marta A Toscano
Journal:  Nat Rev Immunol       Date:  2009-05       Impact factor: 53.106

7.  Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo.

Authors:  P Storti; V Marchica; I Airoldi; G Donofrio; E Fiorini; V Ferri; D Guasco; K Todoerti; R Silbermann; J L Anderson; W Zhao; L Agnelli; M Bolzoni; E Martella; C Mancini; N Campanini; D M Noonan; P G Petronini; A Neri; F Aversa; G D Roodman; N Giuliani
Journal:  Leukemia       Date:  2016-05-20       Impact factor: 11.528

8.  Circulating galectins -2, -4 and -8 in cancer patients make important contributions to the increased circulation of several cytokines and chemokines that promote angiogenesis and metastasis.

Authors:  C Chen; C A Duckworth; B Fu; D M Pritchard; J M Rhodes; L-G Yu
Journal:  Br J Cancer       Date:  2014-01-02       Impact factor: 7.640

9.  Galectin-4 controls intestinal inflammation by selective regulation of peripheral and mucosal T cell apoptosis and cell cycle.

Authors:  Daniela Paclik; Silvio Danese; Uta Berndt; Bertram Wiedenmann; Axel Dignass; Andreas Sturm
Journal:  PLoS One       Date:  2008-07-09       Impact factor: 3.240

10.  Galectin-1-mediated cell adhesion, invasion and cell death in human anaplastic large cell lymphoma: regulatory roles of cell surface glycans.

Authors:  Osamu Suzuki; Masafumi Abe
Journal:  Int J Oncol       Date:  2014-03-04       Impact factor: 5.650

View more
  7 in total

Review 1.  Modulation of the tumor micro-environment by CD8+ T cell-derived cytokines.

Authors:  Mirjam E Hoekstra; Saskia V Vijver; Ton N Schumacher
Journal:  Curr Opin Immunol       Date:  2021-04-13       Impact factor: 7.486

Review 2.  Galectin-8, cytokines, and the storm.

Authors:  Yehiel Zick
Journal:  Biochem Soc Trans       Date:  2022-02-28       Impact factor: 4.919

3.  Differential regulation of fibroblast growth factor receptor 1 trafficking and function by extracellular galectins.

Authors:  Marika Kucińska; Natalia Porębska; Agata Lampart; Marta Latko; Agata Knapik; Małgorzata Zakrzewska; Jacek Otlewski; Łukasz Opaliński
Journal:  Cell Commun Signal       Date:  2019-06-17       Impact factor: 5.712

4.  Galectin-9 Mediates HIV Transcription by Inducing TCR-Dependent ERK Signaling.

Authors:  Florent Colomb; Leila B Giron; Thomas A Premeaux; Brooks I Mitchell; Toshiro Niki; Emmanouil Papasavvas; Luis J Montaner; Lishomwa C Ndhlovu; Mohamed Abdel-Mohsen
Journal:  Front Immunol       Date:  2019-02-20       Impact factor: 7.561

5.  Adult neural stem cells have latent inflammatory potential that is kept suppressed by Tcf4 to facilitate adult neurogenesis.

Authors:  Mohammad Shariq; Vinaya Sahasrabuddhe; Sreevatsan Krishna; Swathi Radha; Ravishankara Bellampalli; Anukriti Dwivedi; Rajit Cheramangalam; Boris Reizis; Jean Hébert; Hiyaa S Ghosh
Journal:  Sci Adv       Date:  2021-05-21       Impact factor: 14.957

Review 6.  Galectokines: The Promiscuous Relationship between Galectins and Cytokines.

Authors:  Lucía Sanjurjo; Esmee C Broekhuizen; Rory R Koenen; Victor L J L Thijssen
Journal:  Biomolecules       Date:  2022-09-13

Review 7.  Utilization of Galectins by Pathogens for Infection.

Authors:  Diyoly Ayona; Pierre-Edouard Fournier; Bernard Henrissat; Benoit Desnues
Journal:  Front Immunol       Date:  2020-08-19       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.